The medtech earnings season kicks off next week with a slew of first quarter results, including Abbott Laboratories, Edwards Lifesciences, Intuitive Surgical, Johnson & Johnson, Roche and Quest Diagnostics, that will help reveal if elective procedures have recovered and if the COVID-19 testing boom has persisted.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,